Background: Autosomal dominant polycystic kidney disease (ADPKD) is the most common hereditary cystic kidney disease and is well known to have extrarenal complications. Cardiovascular complications are of particular clinical relevance because of their morbidity and mortality; however, unclear is why they occur so frequently in patients with ADPKD and whether they are related to the genotypes.

Methods: We extracted and retrospectively analyzed clinical data on patients with ADPKD who underwent echocardiography and whose genotype was confirmed by genetic testing between April 2016 and December 2020. We used next-generation sequencing to compare cardiac function, structural data, and the presence of cardiac valvular disease in patients with 1 of 3 genotypes: , , and non-, .

Results: This retrospective study included 65 patients with ADPKD. Patients were divided into 3 groups: , = 32; , = 12; and non-, , = 21. The prevalence of mitral regurgitation (MR) was significantly higher in the group than in the and non-, group (46.9% vs. 8.3% vs. 19.0%, respectively; = 0.02). In contrast, no significant difference was found for other cardiac valve complications.

Conclusion: This study found a significantly higher prevalence of MR in patients with the genotype than in those with the or non-, genotypes. Physicians may need to perform echocardiography earlier and more frequently in patients with ADPKD and the genotype and to control fluid volume and blood pressure more strictly in these patients to prevent future cardiac events.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC9149474PMC
http://dx.doi.org/10.1159/000520300DOI Listing

Publication Analysis

Top Keywords

patients adpkd
16
kidney disease
12
autosomal dominant
8
dominant polycystic
8
polycystic kidney
8
patients
8
frequently patients
8
adpkd
5
echocardiographic findings
4
findings genotypes
4

Similar Publications

Autosomal dominant polycystic kidney disease (ADPKD) represents the most common inherited kidney disorder leading to kidney failure in a significant percentage of patients over time. Although previously considered as an adult disease, robust evidence demonstrated that clinical manifestations might occur during childhood and adolescence. Therefore, early identification and treatment of the disease are of cardinal importance for pediatricians to ensure the best long-term outcomes.

View Article and Find Full Text PDF

Rational & Objective: Data are limited regarding the long-term efficacy of tolvaptan in adults aged 18-35 years with autosomal dominant polycystic kidney disease (ADPKD) at increased risk of rapid progression. We assessed the effects of tolvaptan within a larger population of younger adults and over longer follow-up than individual clinical trials could provide.

Study Design: Pooled database study.

View Article and Find Full Text PDF

Background And Hypothesis: Gut dysbiosis characterized by an imbalance in pathobionts (Enterobacter, Escherichia and Salmonella) and symbionts (Bifidobacterium, Lactobacillus and Prevotella) can occur during chronic kidney disease (CKD) progression. We evaluated the associations between representative symbionts (Bifidobacterium and Lactobacillus) and pathobionts (Enterobacteriaceae) with kidney function in persons with autosomal dominant polycystic kidney disease (ADPKD).

Methods: In this cross-sectional study, 29 ADPKD patients were matched to 15 controls at a 2:1 ratio.

View Article and Find Full Text PDF

Gene therapy in polycystic kidney disease: A promising future.

J Transl Int Med

December 2024

Division of Nephrology, Shanghai Changzheng Hospital, Second Military Medical University (Naval Medical University), Shanghai 200003, China.

Polycystic kidney disease (PKD) is a genetic disorder marked by numerous cysts in the kidneys, progressively impairing renal function. It is classified into autosomal dominant polycystic kidney disease (ADPKD) and autosomal recessive polycystic kidney disease (ARPKD), with ADPKD being more common. Current treatments mainly focus on symptom relief and slowing disease progression, without offering a cure.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!